Loading...

GOVX GEOVAX LABS INC Capital Structure Changes 8-K Filing

GVX

GVX

GEOVAX LABS INC

(GOVX)

2025 8-K

Summary

Summary

Stock Offering Details

Notification of Deficiency

Financial Statements

Equity Offerings

Financial Statements

Contract Termination

Earnings Report

Stockholder Approvals

Special Meeting Update

Nasdaq Compliance

Quarterly Results

Stockholder Meeting

Share Offering Increase

Stockholder Meeting

Stock Sale Agreement

Stockholder Meeting

Earnings Report

Investment Offering

Award for COVID-19 Vaccine ...

Amendment to Bylaws and Ann...

Investment Offering

Results of Operations and F...

Earnings Report

Reverse Stock Split

Stockholder Meeting

Agreement with Existing War...

Earnings Reports

Earnings Reports

Annual Meeting Results

Equity Offerings

Earnings Reports

External Links:

GeoVax Labs, Inc. announced a registered direct offering on September 30, 2025, selling approximately 3.97 million shares of common stock at $0.63 each, raising about $2.32 million for product advancement and research efforts. Concurrently, the company issued warrants for an additional 11.9 million shares, pending shareholder approval.

AI Assistant

GEOVAX LABS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.